Home > Research > Publications & Outputs > General practitioners' awareness of the recomme...

Research

Links

Text available via DOI:

Keywords

View graph of relations

General practitioners' awareness of the recommendations for faecal immunochemical tests (FITs) for suspected lower gastrointestinal cancers: a national survey

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

General practitioners' awareness of the recommendations for faecal immunochemical tests (FITs) for suspected lower gastrointestinal cancers: a national survey. / Von Wagner, Christian; Stoffel, Sandro Tiziano; Freeman, Madeline et al.
In: BMJ Open, Vol. 9, No. 4, e025737, 11.04.2019.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Von Wagner, C, Stoffel, ST, Freeman, M, Laszlo, HE, Nicholson, BD, Sheringham, J, Szinay, D & Hirst, Y 2019, 'General practitioners' awareness of the recommendations for faecal immunochemical tests (FITs) for suspected lower gastrointestinal cancers: a national survey', BMJ Open, vol. 9, no. 4, e025737. https://doi.org/10.1136/bmjopen-2018-025737

APA

Von Wagner, C., Stoffel, S. T., Freeman, M., Laszlo, H. E., Nicholson, B. D., Sheringham, J., Szinay, D., & Hirst, Y. (2019). General practitioners' awareness of the recommendations for faecal immunochemical tests (FITs) for suspected lower gastrointestinal cancers: a national survey. BMJ Open, 9(4), Article e025737. https://doi.org/10.1136/bmjopen-2018-025737

Vancouver

Von Wagner C, Stoffel ST, Freeman M, Laszlo HE, Nicholson BD, Sheringham J et al. General practitioners' awareness of the recommendations for faecal immunochemical tests (FITs) for suspected lower gastrointestinal cancers: a national survey. BMJ Open. 2019 Apr 11;9(4):e025737. doi: 10.1136/bmjopen-2018-025737

Author

Von Wagner, Christian ; Stoffel, Sandro Tiziano ; Freeman, Madeline et al. / General practitioners' awareness of the recommendations for faecal immunochemical tests (FITs) for suspected lower gastrointestinal cancers : a national survey. In: BMJ Open. 2019 ; Vol. 9, No. 4.

Bibtex

@article{e4ccc928397e4cdb9d6cd3bd7ddbcd14,
title = "General practitioners' awareness of the recommendations for faecal immunochemical tests (FITs) for suspected lower gastrointestinal cancers: a national survey",
abstract = "OBJECTIVES: In July 2017, UK National Institute for Health and Care Excellence (NICE) published a diagnostic guidance (DG30) recommending the use of faecal immunochemical tests (FITs) for symptomatic patients who do not meet the urgent referral pathway for suspected colorectal cancer (CRC). We assessed general practitioners' (GP) awareness of DG30 in primary care 6 months after its publication.DESIGN AND SETTING: Cross-sectional online survey of GPs hosted by an English panel of Primary health care professionals.PARTICIPANTS: In December 2017, 1024 GPs registered on an online panel (M3) based in England took part in an online survey.OUTCOMES AND VARIABLES: We investigated a number of factors including previous experience of using FIT and guaiac faecal occult blood tests (FOBTs), the number of urgent referrals for CRC that GPs have made in the last year and their sociodemographic and professional characteristics that could be associated with their self-reported awareness of the FIT diagnostic guidance.RESULTS: Of the 1024 GPs who completed the survey, 432 (42.2%) were aware of the current recommendation but only 102 (10%) had used it to guide their referrals. Awareness was lowest in North West England compared with London (30.5% vs 44.9%; adjusted OR: 0.55, 95% CI 0.33 to 0.92). Awareness of the FIT guidance was positively associated with test usage after the NICE update (adjusted OR: 13.00, 95% CI 6.87 to 24.61) and having specialist training (adjusted OR: 1.48, 95% CI 1.05 to 2.08). The number of urgent referrals, the previous use of FOBt, GPs' age and gender, work experience and practice size (both in terms of the number of GPs or patients at the practice) were not associated with awareness.CONCLUSIONS: Less than half of GPs in this survey recognised the current guidance on the use of FIT. Self-reported awareness was not systematically related to demographic of professional characteristics.",
keywords = "colorectal, fecal immunochemical test, primary care, symptomatic, two week wait",
author = "{Von Wagner}, Christian and Stoffel, {Sandro Tiziano} and Madeline Freeman and Laszlo, {Helga E} and Nicholson, {Brian D} and Jessica Sheringham and Dorothy Szinay and Yasemin Hirst",
note = "{\textcopyright} Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.",
year = "2019",
month = apr,
day = "11",
doi = "10.1136/bmjopen-2018-025737",
language = "English",
volume = "9",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group Ltd",
number = "4",

}

RIS

TY - JOUR

T1 - General practitioners' awareness of the recommendations for faecal immunochemical tests (FITs) for suspected lower gastrointestinal cancers

T2 - a national survey

AU - Von Wagner, Christian

AU - Stoffel, Sandro Tiziano

AU - Freeman, Madeline

AU - Laszlo, Helga E

AU - Nicholson, Brian D

AU - Sheringham, Jessica

AU - Szinay, Dorothy

AU - Hirst, Yasemin

N1 - © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

PY - 2019/4/11

Y1 - 2019/4/11

N2 - OBJECTIVES: In July 2017, UK National Institute for Health and Care Excellence (NICE) published a diagnostic guidance (DG30) recommending the use of faecal immunochemical tests (FITs) for symptomatic patients who do not meet the urgent referral pathway for suspected colorectal cancer (CRC). We assessed general practitioners' (GP) awareness of DG30 in primary care 6 months after its publication.DESIGN AND SETTING: Cross-sectional online survey of GPs hosted by an English panel of Primary health care professionals.PARTICIPANTS: In December 2017, 1024 GPs registered on an online panel (M3) based in England took part in an online survey.OUTCOMES AND VARIABLES: We investigated a number of factors including previous experience of using FIT and guaiac faecal occult blood tests (FOBTs), the number of urgent referrals for CRC that GPs have made in the last year and their sociodemographic and professional characteristics that could be associated with their self-reported awareness of the FIT diagnostic guidance.RESULTS: Of the 1024 GPs who completed the survey, 432 (42.2%) were aware of the current recommendation but only 102 (10%) had used it to guide their referrals. Awareness was lowest in North West England compared with London (30.5% vs 44.9%; adjusted OR: 0.55, 95% CI 0.33 to 0.92). Awareness of the FIT guidance was positively associated with test usage after the NICE update (adjusted OR: 13.00, 95% CI 6.87 to 24.61) and having specialist training (adjusted OR: 1.48, 95% CI 1.05 to 2.08). The number of urgent referrals, the previous use of FOBt, GPs' age and gender, work experience and practice size (both in terms of the number of GPs or patients at the practice) were not associated with awareness.CONCLUSIONS: Less than half of GPs in this survey recognised the current guidance on the use of FIT. Self-reported awareness was not systematically related to demographic of professional characteristics.

AB - OBJECTIVES: In July 2017, UK National Institute for Health and Care Excellence (NICE) published a diagnostic guidance (DG30) recommending the use of faecal immunochemical tests (FITs) for symptomatic patients who do not meet the urgent referral pathway for suspected colorectal cancer (CRC). We assessed general practitioners' (GP) awareness of DG30 in primary care 6 months after its publication.DESIGN AND SETTING: Cross-sectional online survey of GPs hosted by an English panel of Primary health care professionals.PARTICIPANTS: In December 2017, 1024 GPs registered on an online panel (M3) based in England took part in an online survey.OUTCOMES AND VARIABLES: We investigated a number of factors including previous experience of using FIT and guaiac faecal occult blood tests (FOBTs), the number of urgent referrals for CRC that GPs have made in the last year and their sociodemographic and professional characteristics that could be associated with their self-reported awareness of the FIT diagnostic guidance.RESULTS: Of the 1024 GPs who completed the survey, 432 (42.2%) were aware of the current recommendation but only 102 (10%) had used it to guide their referrals. Awareness was lowest in North West England compared with London (30.5% vs 44.9%; adjusted OR: 0.55, 95% CI 0.33 to 0.92). Awareness of the FIT guidance was positively associated with test usage after the NICE update (adjusted OR: 13.00, 95% CI 6.87 to 24.61) and having specialist training (adjusted OR: 1.48, 95% CI 1.05 to 2.08). The number of urgent referrals, the previous use of FOBt, GPs' age and gender, work experience and practice size (both in terms of the number of GPs or patients at the practice) were not associated with awareness.CONCLUSIONS: Less than half of GPs in this survey recognised the current guidance on the use of FIT. Self-reported awareness was not systematically related to demographic of professional characteristics.

KW - colorectal

KW - fecal immunochemical test

KW - primary care

KW - symptomatic

KW - two week wait

U2 - 10.1136/bmjopen-2018-025737

DO - 10.1136/bmjopen-2018-025737

M3 - Journal article

C2 - 30975679

VL - 9

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 4

M1 - e025737

ER -